Nguyễn Cảnh Hưng, Putaux Jean-Luc, Santoni Gianluca, Tfaili Sana, Fourmentin Sophie, Coty Jean-Baptiste, Choisnard Luc, Gèze Annabelle, Wouessidjewe Denis, Barratt Gillian, Lesieur Sylviane, Legrand François-Xavier
Institut Galien Paris-Sud, CNRS UMR 8612, Univ. Paris-Sud, Université Paris-Saclay, 5 rue Jean-Baptiste Clément, F-92290 Châtenay-Malabry, France.
Centre de Recherches sur les Macromolécules Végétales, CNRS UPR 5301, Univ. Grenoble Alpes, BP 53, F-38401 Grenoble Cedex 9, France.
Int J Pharm. 2017 Oct 15;531(2):444-456. doi: 10.1016/j.ijpharm.2017.07.007. Epub 2017 Jul 8.
This work aimed at preparing new nanoscale assemblies based on an amphiphilic bio-esterified β-cyclodextrin (β-CD), substituted at the secondary face with n-decanoic fatty acid chains (β-CD-C), and monoolein (MO) as new carriers for parenteral drug delivery. Stable binary (β-CD-C/MO) and ternary (β-CD-C/MO/stabilizer) nanoscale assemblies close to 100nm in size were successfully prepared in water by the solvent displacement method. The generated nanoparticles were fully characterized by dynamic light scattering, transmission electron microscopy, small-angle X-ray scattering, residual solvent analysis, complement activation and the contribution of each formulation parameter was determined by principal component analysis. The β-CD-C units were shown to self-organize into nanoparticles with a hexagonal supramolecular packing that was significantly modulated by the molar ratio of the constituents and the presence of a steric or electrostatic stabilizer (DOPE-PEG or DOPA/POPA, respectively). Indeed, nanoparticles differing in morphology and in hexagonal lattice parameters were obtained while the co-existence of multiple mesophases was observed in some formulations, in particular for the β-CD-C/MO/DOPA and β-CD-C/MO/POPA systems. The mixed β-CD-C/MO/DOPE-PEG nanoparticles (49:49:2 in mol%) appeared to be the most suitable for use as a drug delivery system since they contained a very low amount of residual solvent and showed a low level of complement C3 activation.
这项工作旨在制备基于两亲性生物酯化β-环糊精(β-CD)的新型纳米级组装体,β-CD在其二级面上被正癸酸脂肪酸链取代(β-CD-C),并以单油酸甘油酯(MO)作为肠胃外给药的新型载体。通过溶剂置换法在水中成功制备了尺寸接近100nm的稳定二元(β-CD-C/MO)和三元(β-CD-C/MO/稳定剂)纳米级组装体。通过动态光散射、透射电子显微镜、小角X射线散射、残留溶剂分析对生成的纳米颗粒进行了全面表征,并通过主成分分析确定了每个配方参数的作用。结果表明,β-CD-C单元自组装成具有六方超分子堆积结构的纳米颗粒,其结构受到组分摩尔比以及空间位阻或静电稳定剂(分别为DOPE-PEG或DOPA/POPA)的显著调节。实际上,获得了形态和六方晶格参数不同的纳米颗粒,同时在某些配方中观察到了多种中间相的共存,特别是对于β-CD-C/MO/DOPA和β-CD-C/MO/POPA体系。混合的β-CD-C/MO/DOPE-PEG纳米颗粒(摩尔比为49:49:2)似乎最适合用作药物递送系统,因为它们含有极少量的残留溶剂,并且补体C3激活水平较低。